![Michael Schultz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Michael K.
Schultz is a Chief Science Officer at Viewpoint Molecular Targeting, Inc. and a Chief Science Officer at Perspective Therapeutics, Inc. Dr. Schultz was previously employed as a Principal by National Institute of Health Policy and an Associate Professor by University of Iowa.
| Unternehmen | Position | Beginn |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Gründer | 01.01.2008 |
| Unternehmen | Position | Ende |
|---|---|---|
National Institute of Health Policy | Corporate Officer/Principal | - |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institute of Health Policy | |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
